Host genetic factors, such as HLA alleles, are important in human immunodeficiency virus (HIV) infection and its progression to AIDS. HLA class I gene products are involved in peptide presentation, and each allele is responsible for presenting a different set of peptides to cytotoxic T lymphocytes. The increase or decrease in the frequency of certain alleles in HIV-1-positive versus control subjects would suggest that alleles play a role in susceptibility to or protection against this viral infection. In the present study, 56 HIV-1-positive patients in Chaco Province, Argentina, were typed for the HLA-A and HLA-B loci, using polymerase chain reaction and sequence-specific oligonucleotide probes. The frequency of alleles A*24, B*18, and B*39 was increased in HIV-1-positive subjects, suggesting that these alleles play a role in susceptibility to HIV-1 infection. Alleles B*44 and B*55 were not found in HIV-1-positive subjects, suggesting that they have a protective effect against the disease. The P values of the alleles B*39 and B*44 were statistically significant ( ). P ! .05
Both class I and II major histocompatibility complex (MHC) genes have been linked with rapid, slow, or nonprogression to AIDS. Class I alleles B*35 and Cw*04 have been correlated with a rapid progression to AIDS in white patients [4] . Other studies done among white populations have linked class I molecules A29 and B22 to rapid progression; B14 and C8 to nonprogression; B27, B57, and C14 to protection; and B35 and C16 to susceptibility [5] . In Italy, a higher frequency of HLA-A2 has been reported in HIV-1-positive patients, compared with HIV-1-seronegative, at-risk patients (patients with hemophilia), whereas HLA-B52 and -DR4 were decreased in HIV-1-positive patients [6] . In another study, at-risk groups (HIV-1-positive heterosexual drug addicts, children of seropositive mothers, and patients with hemophilia) were analyzed, and antigens B52 and B44 were associated with resistance, whereas B51 was associated with susceptibility [7] . Thus, the studies reported different findings, depending on the populations analyzed.
The objective of this study was to determine the frequency of the different alleles of the HLA class I A and B loci in HIV-1-infected patients in Chaco Province, Argentina, in an effort to determine the presence of certain alleles that could be a factor in susceptibility to or protection against HIV-1 infection.
Materials and Methods
DNA samples. DNA samples were obtained from peripheral blood samples of 56 HIV-1-positive patients of Guaraní and Hispanic genetic backgrounds in Chaco Province. These individuals were analyzed for the A and B loci, using polymerase chain reaction (PCR) and sequence-specific oligonucleotide probes (SSOPs). The DNA samples were prepared by the salting-out method and then were resuspended in distilled water.
Using the same methodology, we previously typed 56 healthy individuals (blood donors and employees at Julio C. Perrando Hospital), to determine the distribution of class I alleles among healthy residents of Chaco. The results, which were reported at the VII Latin American Histocompatibility Workshop (Cartagena, Colombia, August 1998; unpublished data), were used as a reference standard in this study.
Amplification primers. A generic HLA-A amplification was done by using the sequence-specific primer combination AL#15 (GAGGGTCGGGCG(A)GGTCTCAGCCA) and AL#AW (TG-GCCCCTGGTACCCGT), which generated an 846-bp product. The B locus was amplified by using primers 5 -BIn1-57 (GGG-AGGAGCGAGGGGACCGCAG), 3 -BIn3-37 (AGGCCATCC-CCGGCGACCTAT), and 3 -BIn3-AC (AGGCCATCCCGG-GCGATCTAT), which resulted in a 973-bp product.
Amplification conditions. The final reaction volume (100 mL) contained 500 ng of genomic DNA, 200 mM dNTP, 1.5 mM MgCl 2 , 0.3 mM of each primer, 2 U of Taq polymerase (Promega, Madison, WI), and ammonium buffer. Thermal cycler conditions for HLA-A consisted of an initial 5-min denaturation step at 96ЊC, followed by 35 1-min cycles at 96ЊC, 30 s at 60ЊC, 1 min at 72ЊC, and 5 min at 72ЊC. The same conditions were used for the B locus, except the annealing temperature was 65ЊC. The PCR product (5 mL) was analyzed by ethidium-bromide staining in a 2% agarose gel.
Dot-blot hybridization and signal detection. PCR products (2 mL) were denatured, dot-blotted onto charged nylon membrane, and immobilized, using UV irradiation. The membranes were hybridized with 26 SSOPs for HLA-A and 36 SSOPs for HLA-B identification, according to the protocols of the Latin American Histocompatibility Pre-Workshop (1997; organized by the University of Cartagena, Cartagena, Colombia), and also recognized the alleles identified by K. L. Arnett and P. Parham (Tissue Antigens 1995; 45:217-57). These SSOPs were selected from those recommended by the 12th International Histocompatibility Workshop (St. Malo, France, June 1996).
Annealed probes were visualized by use of anti-digoxigeninalkaline-phosphatase-labeled antibody followed by 5 bromo-4-chloro-3-indolyl-phosphate/nitroblue tetrazolium chloride (both from Boehringer-Mannheim, Germany), according to the manufacturer's recommendations. The reaction patterns were analyzed by use of the SSO DAT Oligotyping Program 1996 (Gerard Trainor, St. Mary's University College, Belfast).
Statistical analysis. The objective of the analyses was to examine the association between allele prevalence and HIV-1 seropositivity. For each HLA allele, the proportion of HIV-1-positive patients and control subjects with the allele was compared, using the gene frequency (GF), which was calculated as GF p 1 Ϫ ; AF (antigen frequency) was calculated by using Hal-
dane's method. The degree of association between an HLA allele was expressed as the odds ratio (OR), which was calculated according to Woolf's formula, and P was determined by x 2 analysis or, when appropriate, by Fisher's exact test.
was considered P ! .05 significant [8] .
Results

DNA samples from 56 HIV-1-positive patients of Guaraní
and Hispanic genetic backgrounds from Chaco Province, Argentina, were typed by PCR-SSOP. The GF of HLA class I alleles among these patients was compared with that for healthy control subjects, which we previously reported in the VII Latin American Histocompatibility Workshop; the same methodology was used for both determinations. Tables 1 and 2 show the distribution of A and B alleles in HIV-positive patients and control subjects, ORs, and P and x 2 values for alleles that present significant differences with respect to the healthy population. The ORs for A*26 (2.52), A*31.011/ 12 (2.22), and A*24 (2.78) were elevated, whereas the ORs for alleles A*2301 (0.31) and A*3201 (0.38) were decreased. However, none of these was statistically significant, with only A*24 coming close to significance ( 
Discussion
Our finding that alleles B*18 and B*39 occurred more frequently among HIV-1-positive patients than among control subjects suggests that they play a role in susceptibility to HIV-1 infection. We could not correlate their presence with progression to AIDS, because it is necessary to know the evolution of disease for each patient. Several authors have reported that alleles B*35, B*29, and B*22 are associated with a rapid progression to AIDS, whereas alleles B*14, B*57, B*27, and C*14 are associated with protection against infection and with slow progression to AIDS [5, 6, 9] . A significant absence of alleles B*44 ( ) and B*55 ( ) was observed. Therefore, P p .013 P p .056 the presence of these alleles would suggest protection against HIV-1 infection.
Because 41 statistical tests for the HLA-A and B locus were done, one would expect (by chance alone) ∼2 significant results at the level. To avoid false-positive or -negative results P p .05 due to incorrect assignation, controls were used for each hybridization probe.
There have been reports of protective immunity against HIV infection, and such findings indicate that the protected individuals generate HIV-specific T cell responses in the absence of detectable HIV-specific antibodies [10, 11] . There are persons who have been exposed to HIV (some on multiple occasions), yet they do not seroconvert or show signs of HIV infection. Seronegative individuals who have been exposed to HIV without subsequent seroconversion include persons who have had unprotected sexual intercourse with HIV-positive partners, injection drug users with a known history of needle sharing, sex workers, newborn infants of HIV-positive mothers, recipients of blood or blood products contaminated with HIV, and health care workers who have sustained parenteral exposure to HIVinfected blood or body fluids [10, 11] . These reports include findings of T cell proliferation, HIV peptide-induced interleukin-2 production, and generation of HIV-specific CTLs.
Taken together, these findings seem to indicate that HLA molecules can exercise a primordial function in resistance to HIV infection [12] . There has been a remarkable expansion in our understanding of molecular mechanisms involved in the interaction between MHC class I and the motifs associated with naturally processed and high-affinity binding peptides. Considerable progress has also been made toward clarifying the molecular events involved in the processing and presentation pathways utilized by MHC class I molecules [13] . The discovery of HLA binding supertypes and supermotifs could have important practical and theoretical consequences. In practical terms, the capacity for identifying broadly cross-reactive peptides represents a major advance toward the development of CTL peptide-based immunotherapeutics, because it might allow for broad, effective, and nonethnically biased population coverage, with only a handful of peptide epitopes.
It has been suggested that other factors can play an important role in viral infection and in the progression to AIDS. Kaslow et al. [9] suggest such a role for TAP proteins (transporter proteins coded in the MHC and presenting a certain polymorphism), which are in charge of transporting peptides to the interior of the endoplasmic reticulum, where they interact with class I molecules. Likewise, a mutation in the receptor CCR5 (D32) has been associated with resistance to infection and slow progression to AIDS [14] . Keet et al. [15] report that the impact of HLA was strong and appeared to be independent of the effect of chemokine receptor/ligand polymorphism and antiretroviral treatment.
In conclusion, because of the great genetic variation among our study population, we have gained knowledge of the alleles that can contribute to resistance or susceptibility of HIV-1 infection in Chaco, Argentina. Because of the great ethnic diversity, these findings vary considerably according to the studied populations.
